Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Peres
Prognostic Role of CD4 T-Cell Depletion After Frontline Fludarabine, Cyclophosphamide and Rituximab in Chronic Lymphocytic Leukaemia
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies
Therapeutic Advances in Hematology
Hematology
Tumour Lysis Syndrome After Treatment of Chronic Lymphocytic Leukaemia With Fludarabine.
Postgraduate Medical Journal
Medicine
Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine
Cancer Management and Research
Oncology
Ochroconis Gallopava Endophthalmitis in Fludarabine Treated Chronic Lymphocytic Leukaemia
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Chronic Lymphocytic Leukaemia: The Role of T Cells in a B Cell Disease
British Journal of Haematology
Hematology
Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia
Cancer
Cancer Research
Oncology
The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma
British Journal of Haematology
Hematology
Efficancy of Rituximab With Chlorambucil Regimen in Elderly Patients With Chronic Lymphocytic Leukaemia
Hematology & blood transfusion: interdepartamental collection
